Methodological design for economic evaluation in Public Access Defibrillation (PAD) trial

References 

1. National Center for Health Statistics. Detailed diagnoses and procedures, National Hospital Discharge Survey, 1990. Hyattsville, Md; 1992.
2. Becker LB, Ostrander MP, Barrett J, et al. Outcomes of CPR in a large metropolitan area—where are the survivors?. Ann Emerg Med. 1991;355–361
3. Lombardi G, Gallagher J, Gennis P. Outcome of out-of-hospital cardiac arrest in New York city. The Pre-Hospital Arrest Survival Evaluation (PHASE) study. JAMA. 1994;678–683
4. Holmberg M, Holmberg S, Herlitz J. An alternate estimate of the disappearance rate of ventricular fibrillation in out-of-hospital cardiac arrest in Sweden. Resuscitation. 2001;219–220
5. Cobb LA, Fahrenbruch CE, Olsufka M, et al. Changing incidence of out-of-hospital ventricular fibrillation, 1980-2000. JAMA. 2002;3008–3013
6. Herlitz J, Bang A, Gunnarsson J, et al. Factors associated with survival to hospital discharge among patients hospitalised alive after out of hospital cardiac arrest: change in outcome over 20 years in the community of Goteborg, Sweden. Heart. 2003;25–30
7. Hallstrom AP, Ornato JP, Weisfeldt M, et al. Public-access defibrillation and survival after out-of-hospital cardiac arrest. N Engl J Med. 2004;637–646
8. PAD Investigators. The public access defibrillation: study design and rationale. Resuscitation. 2003;135–147
9. Russell LB, Siegel JE, Daniels N, et al. Cost-effectiveness analysis as a guide to resource allocation in health: roles and limitations. In:  Weinstein MC editors. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996;p. 3–24
10. Gold MR, Siegel JE, Russell LB, et al. Appendix A: summary recommendations. In:  Weinstein MC editors. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996;p. 425
11. Drummond MF, O'Brien BJ, Stoddart GL, et al. Methods for the economic evaluation of health care programs. 2nd ed.. Oxford: Oxford University Press; 1997;
12. Roccaforte WH, Burke WJ, Bayer BL, et al. Validation of a telephone version of the mini-mental state examination. J Am Geriatr Soc. 1992;697–702
13. Stiell IG, Wells GA, Spaite DW, et al. The Ontario Prehospital Advanced Life Support (OPALS) study: rationale and methodology for cardiac arrest patients. Ann Emerg Med. 1998;180–190
14. Stiell IG, Wells GA, Spaite DW, et al. The Ontario Prehospital Advanced Life Support (OPALS) study Part II: rationale and methodology for trauma and respiratory distress patients. OPALS study group. Ann Emerg Med. 1999;256–262
15. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 1997;1576–1583
16. Torrance GW, Furlong W, Feeny D, et al. Multi-attribute preference functions: health utilities index. PharmacoEconomics. 1995;503–520
17. Feeny D, Furlong W, Boyle W, et al. Multi-attribute health status classification systems: health utilities index. PharmacoEconomics. 1995;490–502
18. Feeny D, Furlong W, Torrance GW, et al. Multiattribute and single-attribute utility functions for the health utilities index mark 3 system. Med Care. 2002;113–128
19. Anonymous . S-Plus 2000. Seattle (WA): Data Analysis Products Division, MathSoft Inc.; 1999;
20. Anonymous . SOLAS for missing data analysis. 3.0 ed.. Boston (MA): Statistical Solutions Inc.; 2000;
21. Smith DM. OSWALD. 3.4 ed.. Lancaster: Lancaster University Department of Mathematics and Statistics; 2000;
22. TreeAge Software I. Decision Analysis by TreeAge. DATA for Windows. Version 3.5 User's Manual. Boston, MA; 1999.
23. Barber JA, Thompson SG. Analysis and interpretation of cost data in randomised controlled trials: review of published studies. BMJ. 1998;1195–2000
24. Briggs AH, O'Brien BJ. The death of cost-minimization analysis?. Health Econ Lett. 2000;3–10
25. Etzioni RD, Feuer EJ, Sullivan SD, et al. On the use of survival analysis techniques to estimate medical care costs. J Health Econ. 1999;365–380
26. Hallstrom AP, Sullivan SD. On estimating costs for economic evaluation in failure time studies. Med Care. 1998;433–436
27. Little RJA, Rubin DB. Statistical analysis with missing data. In:  Watson GS editors. Wiley series in probability and mathematical statistics. New York: John Wiley and Sons; 1987;
28. Rubin DB. Multiple imputation for nonresponse in surveys. New York: Wiley; 1987;
29. Graham JW, Schafer JL. On the performance of multiple imputation for multivariate data with small sample size. In:  Hoyle RH editors. Statistical strategies for small sample research. London: SAGE Publications; 1999;p. 1–32
30. Efron B, Tibshirani RJ. An introduction to the bootstrap. New York: Chapman and Hall; 1993;
31. Sonnenberg FA, Beck JR. Markov models in medical decision making: a practical guide. Med Decis Making. 1993;322–338
32. Naimark D, Krahn MD, Naglie G, et al. Primer on medical decision analysis: part 5-working with Markov processes. Med Decis Making. 1997;152–159
33. O'Brien BJ, Connolly SJ, Goeree R, et al. Cost-effectiveness of the implantable cardioverter-defibrillator: results from the Canadian Implantable Defibrillator Study (CIDS). Circulation. 2001;1416–1421
34. Briggs A, Sculpher M, Buxton M. Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis. Health Econ. 1994;95–104
35. Doubilet P, Begg CB, Weinstein MC, et al. Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach. Med Decis Making. 1985;157–177
36. Critchfield GC, Willard KE. Probabilistic analysis of decision trees using Monte Carlo simulation. Med Decis Making. 1986;86–92
37. van Hout BA, al Maiwenn J, Gordon GS, et al. Costs, effects and C/E ratios alongside a clinical trial. Health Econ. 1994;309–319
38. Dowie J. Clinical trials and economic evaluations? No, there are only evaluations. Health Econ. 1997;87–89
39. Pell JP, Sirel JM, Marsden AK, et al. Potential impact of public access defibrillators on survival after out of hospital cardiopulmonary arrest: retrospective cohort study. BMJ. 2002;515
40. Anonymous . Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care. International consensus on science. Circulation. 2000;1–291
41. Nichol G, Hallstrom A, Ornato JP, et al. Potential cost-effectiveness of public access defibrillation in the United States. Circulation. 1998;1315–1320
42. Nichol G, Laupacis A, Stiell I, et al. A cost-effectiveness analysis of potential improvements to emergency medical services for victims of out-of-hospital cardiac arrest. Ann Emerg Med. 1996;711–720
43. Groeneveld PW, Kwong JL, Liu Y, et al. Cost-effectiveness of automated external defibrillators on airlines. JAMA. 2001;1482–1489
44. Valenzuela TD, Roe DJ, Nichol G, et al. Outcomes of rapid defibrillation by security officers after cardiac arrest in casinos. N Engl J Med. 2000;1206–1209
45. Caffrey SL, Willoughby PJ, Pepe PE, et al. Public use of automated external defibrillators. N Engl J Med. 2002;1242–1247
46. Bloom BS, Fendrick AM. Timing and timeliness in medical care evaluation. PharmacoEconomics. 1996;183–187
47. Boyle M, Furlong W, Torrance G, et al. Reliability of the health utilities index—Mark III used in the 1991 cycle 6 Canadian General Social Survey Health Questionnaire. Qual Life Res. 1995;249–257
48. Nichol G, Stiell IG, Hebert P, et al. What is the quality of life of survivors of cardiac arrest? A prospective study. Acad Emerg Med. 1999;95–102
49. Rubin DB, Schenker N. Multiple imputation for interval estimation from simple random samples with ignorable nonresponse. J Am Stat Assoc. 1986;366–374
50. Hsiao WC, Braun P, Dunn D, et al. Resource-based relative values: an overview. JAMA. 1988;2347–2353
51. Hsiao WC, Braun P, Dunn D, et al. Results and policy implications of the resource based relative-value study. N Engl J Med. 1988;881–888
52. Anonymous . In: 2001 drug topics red book. New York: Medical Economics Data Inc.; 2001;p. 800